Stocks across several sectors swung as dealmaking, analyst actions and corporate updates reshaped expectations for earnings and growth. MarineMax jumped after agreeing to be acquired in an all-cash transaction backed by Blackstone Infrastructure’s Safe Harbor Marinas, while Varex Imaging surged on a pending acquisition by Teledyne Technologies. Elsewhere, AI-linked infrastructure names pulled back, and multiple companies moved sharply after guidance, regulatory outcomes, or trial results.
Key takeaways
- MarineMax surged 46% after a planned $1.5 billion cash acquisition agreement, signaling investor optimism around consolidation in the marine marina market.
- Varex Imaging rose 48% as Teledyne agreed to buy it for $18.90 per share in cash, reinforcing merger-related upside for shareholders.
- Data analytics and digital healthcare saw volatility: Verisk Analytics fell more than 5% following a court ruling tied to a $2.35 billion acquisition, while Doximity dropped 5%.
- AI infrastructure stocks declined, with notable weakness in photonics-related names and a sector ETF sliding about 1%, reflecting investor caution around the near-term AI supply-chain outlook.
- Guidance and trial results drove sharp single-name moves, including Monday.com’s decline on softer guidance and AbCellera Biologics’ 43% rally after Phase 2 data.
What drove the biggest stock moves
Several of the day’s largest winners were propelled by acquisition news. MarineMax agreed to be acquired by Blackstone Infrastructure’s Safe Harbor Marinas for $53 per share in cash, valuing the transaction at about $1.5 billion. The companies said the deal is expected to close by the end of 2026.
In a separate transaction, Teledyne Technologies agreed to acquire Varex Imaging for $18.90 per share in cash, a deal expected to close in early 2027. Teledyne shares rose only marginally, while Varex surged, reflecting the market’s focus on the target’s takeover premium and expected completion timeline.
Corporate updates also drove large dislocations. Verisk Analytics tumbled more than 5% after a Delaware judge ruled it must proceed with its $2.35 billion acquisition of AccuLynx. According to the report, Verisk had previously terminated the deal in December after a Federal Trade Commission review was not completed by the transaction’s termination date.
AI and infrastructure pressure reshaped parts of the market
Stocks tied to artificial intelligence infrastructure slid, according to the report. The Global X Data Center & Digital Infrastructure ETF fell about 1%, while Corning dropped more than 3%. Photonics companies Coherent and Lumentum fell sharply—down 12% and more than 6%, respectively—pointing to weakness across equipment and components that serve AI data center buildouts.
Investors also appeared to be differentiating between broad AI beneficiaries and specific sub-sectors. The pullback in data center-linked exposures contrasted with several single-stock positives elsewhere, suggesting that the market may be rotating within the AI supply chain based on perceived near-term demand, margins, or competitive dynamics rather than taking a uniform risk-off stance.
Analyst moves and guidance misses hit software, storage and consumer-tech names
Not all declines were tied to company fundamentals; analyst actions played a role as well. NetApp gained about 6% after Morgan Stanley upgraded the stock to equal weight from underweight. The bank cited improving storage fundamentals that could support higher earnings estimates, while also noting that valuation at peak price-to-earnings already reflects meaningful credit for the improving outlook.
Apple fell 2% after Jefferies downgraded the company to underperform from hold. Jefferies said, based on supply chain checks, that an all-glass iPhone—something Apple has never publicly announced—appears to have been canceled. The report said this could increase pressure on Apple as it tries to shift demand toward higher-priced devices to help offset rising memory costs.
Monday.com sank more than 6% after guidance disappointed. The report said the company expects current-quarter revenue in a range of $368 million to $370 million, below the FactSet consensus of $372.8 million. Full-year revenue guidance was roughly in line with expectations, but the near-term read-through appeared to have outweighed that stability for investors.
In software, N-able dropped more than 37% after giving disappointing current-quarter guidance. The report said N-able expects third-quarter revenue of about $135 million versus nearly $142 million in the FactSet consensus. Adjusted EBITDA of $41.0 million to $42.0 million also fell short of the $46.3 million consensus estimate.
Insurance, semiconductors and biotech: earnings, capital plans and trial outcomes
Berkshire Hathaway rose nearly 2% after saying Saturday that operating earnings grew 16% in the second quarter. The report said manufacturing, service and retailing earnings showed strong growth, as did energy profits. Insurance earnings were weaker, with investment income declining 9%.
Intel fell nearly 3% after announcing it will offer $15 billion in common stock. The report said the company plans to use proceeds for general corporate purposes, which may include capital expenditures and working capital. For investors, the move likely raised questions about near-term dilution versus long-term investment needs—especially as the semiconductor sector continues to weigh capex intensity.
In biotech, AbCellera Biologics surged 43% after reporting strong Phase 2 clinical results for its medication to treat hot flashes caused by menopause. The company said Phase 2 results showed best-in-class reductions in both frequency and severity of moderate-to-severe vasomotor symptoms after a single dose.
Other biotech moves were less favorable. Sionna Therapeutics collapsed 92% after its cystic fibrosis drug failed to meet key endpoints in a proof-of-concept trial. The company said it was disappointed with the results and would not advance the drug as an add-on to standard of care.
What to watch next
Markets will likely stay sensitive to deal progression and regulatory timelines for announced acquisitions, including MarineMax’s and Teledyne’s pending moves. Investors may also monitor follow-through on AI supply-chain weakness, especially if guidance and demand commentary from key component suppliers change the near-term outlook. With analyst notes already reshaping expectations for companies including Apple and NetApp, the next catalyst will likely come from upcoming earnings releases, guidance updates, and any further regulatory developments tied to large merger cases.
